Rahul Rao, MD
Vascular Neurology · Fort Worth, TXNPI 1215467246
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.4%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Penumbra, Inc. at 49.0% of the total. Reporting peaked in 2024 at $6,578 and has fallen 83.6% since, to $1,078 in 2025.
Across 90 payments — averaging $103.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$5K
- Medical Device Business Services, Inc.$2K
- Imperative Care, Inc$616
- Medtronic$567
- AstraZeneca$534
- Stryker$483
- plus $992 from 13 others
What the payments were for
- Travel & lodging$4,14145%
- Food & beverage$5,14455%
- Gifts$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 28 | $4,555 |
| Medical Device Business Services, Inc. | 15 | $1,542 |
| Imperative Care, Inc | 12 | $616 |
| Medtronic | 5 | $567 |
| AstraZeneca(2 entities) | 5 | $534 |
| Stryker | 7 | $483 |
| EMD Serono, Inc. | 4 | $225 |
| Inari Medical, Inc. | 1 | $144 |
| Microvention, Inc. | 3 | $138 |
| Genentech USA, Inc. | 1 | $133 |
| CSL Behring | 1 | $125 |
| Biogen | 1 | $78 |
| Qapel Medical Inc | 1 | $47 |
| Johnson & Johnson | 1 | $25 |
| Terumo Medical Corporation | 1 | $19 |
| Philips North America LLC | 1 | $16 |
| Inspiremd Ltd | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
| UCB, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Penumbra System$3,737
- CEREPAK UNIFORM$1,223
- TRUFILL$1,223
- Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$1,223
- Embotrap$1,223
- Pipeline$261
- ZOOM 88-T LARGE DISTAL PLATFORM$250
- SURPASS EVOLVE$162
- AXS VECTA 71$159
- RED 72$155
- FLOWTRIEVER CATHETER, S$144
- CT THROMBECTOMY SYSTEM KIT$144
- Activase$133
- ULTOMIRIS$127
- ANDEXXA$125
- Hizentra$125
- SOLIRIS$121
- ZOOM 7X CATHETER$118
- Mavenclad$106
- Penumbra Coil 400$101
How this compares
$9,289 in reported general payments places this provider in the 80th percentile of 76 vascular neurology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 15 | $35 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Fort Worth
- Salman TariqueFort Worth$1K
- Ameer HassanHarlingen$1M
- John VolpiHouston$407K
- Lee BirnbaumSan Antonio$195K
- Amrou SarrajHouston$182K
- Sunil ShethHouston$54K
- Steven WarachAustin$32K
- Jefferson MileyAustin$28K
- Hamidreza SaberAustin$22K
- Haris KamalHouston$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.